Despite a legal headquarters relocation, Medtronic is retaining its workforce in Minnesota, which remains a national leader based on med-tech jobs and concentration of medical device manufacturers.
Health Care + Med Tech
Bio-Techne has agreed to purchase ProteinSimple for $300 million in cash in a deal expected to close this summer.
The company said that, while it plans to relocate its headquarters from Fridley to Ireland, it will retain its “operational headquarters” in the Twin Cities.
A two-person committee appointed by the med-tech giant concluded that allegations against Medtronic’s leaders are “without merit”; it’s now seeking dismissal of shareholder lawsuits.
Steele Fitness is further expanding its gym membership program and plans for five to seven new gym locations by the end of the year.
Although Bloomberg reported that the potential deal is still in its early stages, if the acquisition occurs, it could result in Medtronic relocating its legal headquarters to London.
Clinicians can use HealthKit to define custom ranges for metrics like heart rate and blood pressure for the patient.
Now that CardioMEMS’ heart-monitoring technology has been approved, St. Jude is executing its option to buy the company, in which it had previously invested.
Thousands of Minnesotans could be due payments from two life insurance companies that failed to pay beneficiaries when policy holders died.
St. Paul-based med-tech company MGC Diagnostics Corporation announced that CEO Gregg Lehman is leaving the firm to become CEO of a healthcare and wellness program provider.
The majority of Minnesota-based Bayer Interventional’s 350 employees work in Coon Rapids but Boston Scientific said it’s still determining whether it will keep all the existing workers.
Killian Rieder’s “Elo” pillow is equipped with speakers that play music or tell children’s stories, but only when the child’s head is resting on it.
Medtronic, which did not admit wrongdoing, expects to record a fourth-quarter charge of up to $140 million to cover its latest settlement and the estimated cost of additional settlements.
Industry group LifeScience Alley tallies $60 million raised in the first quarter, a 25 percent increase.
Axis Clinicals' plant will employ 100 workers at a former Wal-Mart site in Dilworth.
Vascular Solutions reported a 15 percent jump in quarterly sales but costs tied to its ongoing legal battle with Boston Scientific caused the company to revise its earnings outlook.
The FDA sent a warning letter to American Medical Systems, identifying issues related to “process validation, risk analysis, and corrective and preventive action procedures.”
The U.S. Court of Appeals removed a preliminary injunction that Vascular Solutions previously won against Boston Scientific.